» Articles » PMID: 28702509

Loss-of-function Variants of in Intellectual Disability Without Seizures

Overview
Journal Neurol Genet
Date 2017 Jul 14
PMID 28702509
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To determine the functional effect of missense mutations in 2 children with intellectual disability and developmental delay but no seizures.

Methods: Genomic DNA was analyzed by next-generation sequencing. variants were introduced into the Na1.6 complementary DNA by site-directed mutagenesis. Channel activity was measured electrophysiologically in transfected ND7/23 cells. The stability of the mutant channels was assessed by Western blot.

Results: Both children were heterozygous for novel missense variants that altered conserved residues in transmembrane segments of Na1.6, p.Gly964Arg in D2S6 and p.Glu1218Lys in D3S1. Both altered amino acids are evolutionarily conserved in vertebrate and invertebrate channels and are predicted to be deleterious. Neither was observed in the general population. Both variants completely prevented the generation of sodium currents in transfected cells. The abundance of Na1.6 protein was reduced by the Glu1218Lys substitution.

Conclusions: Haploinsufficiency of is associated with cognitive impairment. These observations extend the phenotypic spectrum of mutations beyond their established role in epileptic encephalopathy (OMIM#614558) and other seizure disorders. should be considered as a candidate gene for intellectual disability, regardless of seizure status.

Citing Articles

Transcriptomic analyses of human brains with Alzheimer's disease identified dysregulated epilepsy-causing genes.

Eteleeb A, Alves S, Buss S, Shafi M, Press D, Garcia-Cairasco N medRxiv. 2025; .

PMID: 39974070 PMC: 11838929. DOI: 10.1101/2025.01.02.25319900.


Genome-wide association analysis and admixture mapping in a Puerto Rican cohort supports an Alzheimer disease risk locus on chromosome 12.

Akgun B, Feliciano-Astacio B, Hamilton-Nelson K, Scott K, Rivero J, Adams L Front Aging Neurosci. 2024; 16:1459796.

PMID: 39295643 PMC: 11408238. DOI: 10.3389/fnagi.2024.1459796.


Allele-Specific Editing of a Dominant SCN8A Epilepsy Variant Protects against Seizures and Lethality in a Murine Model.

Yu W, Hill S, Huang Y, Zhu L, Demetriou Y, Ziobro J Ann Neurol. 2024; 96(5):958-969.

PMID: 39158034 PMC: 11496010. DOI: 10.1002/ana.27053.


Expanding the genotype-phenotype spectrum in SCN8A-related disorders.

Hebbar M, Al-Taweel N, Gill I, Boelman C, Dean R, Goodchild S BMC Neurol. 2024; 24(1):31.

PMID: 38233770 PMC: 10792783. DOI: 10.1186/s12883-023-03478-y.


Possibilities and limitations of antisense oligonucleotide therapies for the treatment of monogenic disorders.

Lauffer M, van Roon-Mom W, Aartsma-Rus A Commun Med (Lond). 2024; 4(1):6.

PMID: 38182878 PMC: 10770028. DOI: 10.1038/s43856-023-00419-1.


References
1.
Petrovski S, Wang Q, Heinzen E, Allen A, Goldstein D . Genic intolerance to functional variation and the interpretation of personal genomes. PLoS Genet. 2013; 9(8):e1003709. PMC: 3749936. DOI: 10.1371/journal.pgen.1003709. View

2.
Gilissen C, Hehir-Kwa J, Tjwan Thung D, van de Vorst M, van Bon B, Willemsen M . Genome sequencing identifies major causes of severe intellectual disability. Nature. 2014; 511(7509):344-7. DOI: 10.1038/nature13394. View

3.
. Prevalence and architecture of de novo mutations in developmental disorders. Nature. 2017; 542(7642):433-438. PMC: 6016744. DOI: 10.1038/nature21062. View

4.
Wagnon J, Barker B, Hounshell J, Haaxma C, Shealy A, Moss T . Pathogenic mechanism of recurrent mutations of SCN8A in epileptic encephalopathy. Ann Clin Transl Neurol. 2016; 3(2):114-23. PMC: 4748308. DOI: 10.1002/acn3.276. View

5.
Rauch A, Wieczorek D, Graf E, Wieland T, Endele S, Schwarzmayr T . Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study. Lancet. 2012; 380(9854):1674-82. DOI: 10.1016/S0140-6736(12)61480-9. View